The three year grant, worth over £140,000, forms part of over £4.2 million invested in research by Campaign in the last year.
Dr Martin will study a group of molecules called redox proteins which are thought to help breast cancer cells survive. By examining 2,000 breast cancer samples he hopes to discover whether these proteins play a role in the development of breast cancer and whether they are resistant to breast cancer treatments such as chemotherapy and radiotherapy.
Dr Martin said “The results of this project may help clinicians to select the most appropriate treatments for patients and the development of breast cancer treatments in the future.”
Pamela Goldberg, Chief Executive, Breast Cancer Campaign said “Thanks to real progress in breast cancer research we have seen significant improvements in diagnosis, treatment and survival. Breast cancer research is saving lives and our mission is to beat breast cancer by funding world class research projects such as Dr Martin’s to keep up the momentum of bringing us closer to a cure.”
Emma Thorne | alfa
World first: Massive thrombosis removed during early pregnancy
20.07.2017 | Universitätsspital Bern
Therapy of preterm birth in sight?
19.07.2017 | Universitätsspital Bern
21.07.2017 | Event News
19.07.2017 | Event News
12.07.2017 | Event News
21.07.2017 | Earth Sciences
21.07.2017 | Power and Electrical Engineering
21.07.2017 | Physics and Astronomy